Cipher Pharmaceuticals Inc  

(Public, TSE:DND)   Watch this stock  
Find more results for DND
0.00 (0.00%)
Delayed:   12:12PM EDT
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 7.58 - 7.64
52 week 3.56 - 9.59
Open 7.58
Vol / Avg. 1,005.00/48,757.00
Mkt cap 190.34M
P/E 8.48
Div/yield     -
EPS 0.90
Shares 24.98M
Beta -1.47
Inst. own     -

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 135.96% 92.43%
Operating margin 83.06% 67.22%
EBITD margin - 71.39%
Return on average assets 156.77% 64.43%
Return on average equity 229.15% 97.60%
Employees 13 -
CDP Score - -


Unit 16, 5650 Tomken Rd.
+1-905-6025840 (Phone)
+1-905-6020628 (Fax)

Website links


Cipher Pharmaceuticals Inc. (Cipher) is a specialty commercial stage pharmaceutical company focused on the development and commercialization of formulations of marketed molecules. It develops formulations of marketed drugs using third party drug delivery technologies. Its CIP-FENOFIBRATE is a formulation of the active ingredient fenofibrate, which is used in the treatment of Hyperlipidemia. Its CIP-TRAMADOL ER is a sustained-release formulation of the active ingredient tramadol, which is used for the management of moderate to moderately severe pain. CIP-ISOTRETINOIN is based on the Lidose delivery system and was in-licensed from Galephar Pharmaceutical Research, Inc. (Galephar). Its marketing rights to CIPISOTRETINOIN include the Americas and the Pacific Rim. During the year ended December 31, 2012, Cipher obtained exclusive license and distribution rights in Canada to market the Betesil Patch, a self-adhesive medicated plaster for the treatment of inflammatory skin conditions.

Officers and directors

Gerald P. McDole Chairman of the Board
Age: 74
Larry Andrews President, Chief Executive Officer, Director
Norman C. Evans Chief Financial Officer, Secretary
Jason A. Gross Pharm D. Vice President - Scientific Affairs
Thomas G. Wellner Director
Stefan Aigner M.D. Independent Director
William D. Claypool M.D. Independent Director
Age: 61
John D. Mull M.D. Independent Director
Stephen R. Wiseman Independent Director
Age: 67